Snowden Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Sell |
1,400
-182
| -12% | -$27.6K | 0.01% | 1149 |
|
|
2025
Q1 | $238K | Sell |
1,582
-877
| -36% | -$132K | 0.01% | 1090 |
|
|
2024
Q4 | $454K | Sell |
2,459
-406
| -14% | -$74.9K | 0.01% | 811 |
|
|
2024
Q3 | $564K | Buy |
2,865
+954
| +50% | +$188K | 0.02% | 718 |
|
|
2024
Q2 | $395K | Sell |
1,911
-204
| -10% | -$42.1K | 0.01% | 862 |
|
|
2024
Q1 | $573K | Sell |
2,115
-219
| -9% | -$59.3K | 0.02% | 701 |
|
|
2023
Q4 | $552K | Buy |
2,334
+218
| +10% | +$51.5K | 0.02% | 659 |
|
|
2023
Q3 | $415K | Sell |
2,116
-169
| -7% | -$33.1K | 0.02% | 728 |
|
|
2023
Q2 | $480K | Buy |
2,285
+391
| +21% | +$82.2K | 0.02% | 755 |
|
|
2023
Q1 | $382K | Buy |
1,894
+239
| +14% | +$48.2K | 0.01% | 846 |
|
|
2022
Q4 | $361K | Sell |
1,655
-187
| -10% | -$40.7K | 0.02% | 852 |
|
|
2022
Q3 | $362K | Buy |
1,842
+136
| +8% | +$26.7K | 0.02% | 805 |
|
|
2022
Q2 | $365K | Sell |
1,706
-717
| -30% | -$153K | 0.02% | 775 |
|
|
2022
Q1 | $688K | Buy |
2,423
+2,062
| +571% | +$585K | 0.03% | 537 |
|
|
2021
Q4 | $136K | Sell |
361
-1,619
| -82% | -$610K | 0.01% | 759 |
|
|
2021
Q3 | $817K | Buy |
1,980
+178
| +10% | +$73.5K | 0.04% | 407 |
|
|
2021
Q2 | $667K | Buy |
+1,802
| New | +$667K | 0.03% | 461 |
|